Smoking flavored e-cigarettes can have a detrimental effect on endothelial function, leaving e-cig users prone to poor vascular health and heart disease, researchers report in the June edition of the Journal of the American College of Cardiology.

The popular anticoagulant dabigatran is no more effective than aspirin when it comes to preventing recurrent stroke in patients with a history of embolic events, researchers reported in the New England Journal of Medicine May 16.

Researchers have linked a specific type of immune cell found in arterial plaque to increased probability of a stroke or mini-stroke.  

Fragmin (dalteparin sodium), a type of heparin that works as an anticoagulant, was approved by the FDA May 16 to treat symptomatic venous thromboembolism (VTE) in pediatric patients aged one month and up.

A dietary supplement commonly used to relieve osteoarthritis and joint pain may also double as a cardioprotector, Tulane University researchers reported in The BMJ May 14.

A team funded by the National Institutes of Health has succeeded in growing human acellular vessels—implantable, bioengineered human blood vessels—to replace damaged vasculature in patients with end-stage kidney failure.

The migraine medication galcanezumab might protect against adverse CV events in patients taking the drug for episodic headaches, according to research presented at the American Academy of Neurology’s 2019 meeting in Philadelphia.

Pennsylvania-based health company Orchestra BioMed has obtained FDA breakthrough device designation for its Virtue sirolimus-eluting balloon (SEB), according to a statement issued April 24.